ArticleDevelopmental cell2010

CRL2(LRR-1) targets a CDK inhibitor for cell cycle control in C. elegans and actin-based motility regulation in human cells.

Natalia G Starostina et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.